Standout Papers

Pharmacogenomics Knowledge for Personalized Medicine 2009 2026 2014 2020 1.3k
  1. Pharmacogenomics Knowledge for Personalized Medicine (2012)
    Michelle Whirl‐Carrillo, Ellen M. McDonagh et al. Clinical Pharmacology & Therapeutics
  2. Doxorubicin pathways (2010)
    Caroline F. Thorn, Connie Oshiro et al. Pharmacogenetics and Genomics
  3. Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data (2009)
    Teri E. Klein, Niclas Eriksson et al. New England Journal of Medicine
  4. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics (2016)
    Sarah S. Kalia, Sherri J. Bale et al. Genetics in Medicine
  5. CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network (2011)
    MV Relling, Teri E. Klein Clinical Pharmacology & Therapeutics
  6. Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update (2013)
    Stuart A. Scott, Katrin Sangkuhl et al. Clinical Pharmacology & Therapeutics
  7. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors (2015)
    J K Hicks, Katrin Sangkuhl et al. Clinical Pharmacology & Therapeutics
  8. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing (2015)
    Kelly A. Birdwell, Brian S. Decker et al. Clinical Pharmacology & Therapeutics
  9. Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing (2011)
    J. A. Johnson, Li Gong et al. Clinical Pharmacology & Therapeutics
  10. Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update (2014)
    Kristine R. Crews, Andrea Gaedigk et al. Clinical Pharmacology & Therapeutics
  11. Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update (2016)
    Katrin Sangkuhl, JJ Swen et al. Clinical Pharmacology & Therapeutics
  12. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update (2017)
    JA Johnson, Li Gong et al. Clinical Pharmacology & Therapeutics
  13. Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing (2011)
    Mary V. Relling, William J. Sandborn et al. Clinical Pharmacology & Therapeutics
  14. Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update (2018)
    Mary V. Relling, Matthias Schwab et al. Clinical Pharmacology & Therapeutics
  15. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update (2017)
    Ursula Amstutz, Linda M. Henricks et al. Clinical Pharmacology & Therapeutics
  16. An Evidence‐Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine (2021)
    Michelle Whirl‐Carrillo, Rachel Huddart et al. Clinical Pharmacology & Therapeutics
  17. Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group (2019)
    Kelly E. Caudle, Katrin Sangkuhl et al. Clinical and Translational Science
  18. Prediction of CYP2D6 phenotype from genotype across world populations (2016)
    Andrea Gaedigk, Katrin Sangkuhl et al. Genetics in Medicine
  19. Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC) (2016)
    Kelly E. Caudle, Henry M. Dunnenberger et al. Genetics in Medicine
  20. Preemptive Clinical Pharmacogenetics Implementation: Current Programs in Five US Medical Centers (2014)
    Henry M. Dunnenberger, Kristine R. Crews et al. The Annual Review of Pharmacology and Toxicology
  21. The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update (2014)
    Laura B. Ramsey, Samuel G. Johnson et al. Clinical Pharmacology & Therapeutics
  22. ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG) (2021)
    David T. Miller, Kristy Lee et al. Genetics in Medicine
  23. The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database (2017)
    Andrea Gaedigk, Magnus Ingelman‐Sundberg et al. Clinical Pharmacology & Therapeutics
  24. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy (2018)
    Matthew P. Goetz, Katrin Sangkuhl et al. Clinical Pharmacology & Therapeutics
  25. Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti‐Inflammatory Drugs (2020)
    Katherine N. Theken, Craig R. Lee et al. Clinical Pharmacology & Therapeutics
  26. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing (2020)
    John J. Lima, Cameron D. Thomas et al. Clinical Pharmacology & Therapeutics
  27. PharmVar GeneFocus: CYP2B6 (2021)
    Zeruesenay Desta, Li Gong et al. Clinical Pharmacology & Therapeutics
  28. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants (2023)
    Chad Bousman, James M. Stevenson et al. Clinical Pharmacology & Therapeutics
  29. ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG) (2023)
    David T. Miller, Kristy Lee et al. Genetics in Medicine

Immediate Impact

25 by Nobel laureates 44 from Science/Nature 87 standout
Sub-graph 1 of 22

Citing Papers

Theranostic Fluorescent Probes
2024 Standout
Accurate proteome-wide missense variant effect prediction with AlphaMissense
2023 StandoutScienceNobel
12 intermediate papers

Works of Teri E. Klein being referenced

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics
2016 Standout
Pharmacogenomics Knowledge for Personalized Medicine
2012 Standout
and 10 more

Author Peers

Author Last Decade Papers Cites
Teri E. Klein 12310 6937 5181 6089 349 28.9k
Munir Pirmohamed 8227 5843 1828 5109 590 32.8k
Michel Eichelbaum 11713 4626 2281 6672 332 24.8k
Magnus Ingelman‐Sundberg 17831 10603 2938 2932 523 34.7k
Howard L. McLeod 6442 9356 3068 2578 476 26.0k
Richard M. Weinshilboum 4926 8559 4613 2896 403 23.5k
Ann K. Daly 9680 4205 1753 2285 276 20.0k
Mary V. Relling 7164 8420 3128 12014 379 32.6k
William E. Evans 5644 9240 3018 11140 381 33.3k
Richard B. Kim 5650 3640 1217 4683 241 18.1k
David A. Flockhart 5420 3842 3836 1238 252 15.0k

All Works

Loading papers...

Rankless by CCL
2026